{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:58:44Z","timestamp":1769633924985,"version":"3.49.0"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE:<\/jats:title>\n                  <jats:p>Our aim was to evaluate the clinical profile, treatment, and outcome of ceftriaxone-associated postrenal acute renal failure (PARF) in children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>We retrospectively studied 31 consecutive cases from 2003 to 2012 for PARF after ceftriaxone treatment. There was no past history of urolithiasis or nephropathy in these children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>The average time of ceftriaxone administration before PARF was 5.2 days. The major symptoms apart from anuria included flank pain (&amp;gt;3 years old, 25\/25), excessive crying (&amp;lt;3 years, 6\/6), and vomiting (19\/33). Ultrasound showed mild hydronephrosis (25\/31) and ureteric calculi (11\/31). Nine children recovered after 1 to 4 days of pharmacotherapy. Twenty-one children who were resistant to pharmacotherapy underwent retrograde ureteral catheterization. After catheterization of their ureters, normal urine flow was observed, and the symptoms subsided immediately. Catheter insertion failed in 1 child who subsequently underwent 3 sessions of hemodialysis before normal urination was restored. Ceftriaxone was verified to be the main component of the calculi in 4 children by tandem mass spectrometric analysis. The recovery was complete in all cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Ceftriaxone therapy in children may cause PARF. Early diagnosis and prompt pharmacological therapy are important in relieving the condition. Retrograde ureteral catheterization is an effective treatment of those who fail to respond to pharmacotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2013-2103","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T04:56:53Z","timestamp":1395723413000},"page":"e917-e922","source":"Crossref","is-referenced-by-count":20,"title":["Ceftriaxone and Acute Renal Failure in Children"],"prefix":"10.1542","volume":"133","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiying","family":"Chen","sequence":"additional","affiliation":[{"name":"Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"issue":"3","key":"2021120903171812500_B1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jac\/10.3.207","article-title":"Ceftriaxone: renal and biliary excretion and effect on the colon microflora.","volume":"10","author":"Arvidsson","year":"1982","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2021120903171812500_B2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jac\/25.4.689","article-title":"Incidence of gallbladder lithiasis after ceftriaxone treatment.","volume":"25","author":"Cometta","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"8625","key":"2021120903171812500_B3","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(88)90596-X","article-title":"Reversible ceftriaxone-associated biliary pseudolithiasis in children.","volume":"2","author":"Schaad","year":"1988","journal-title":"Lancet"},{"issue":"11","key":"2021120903171812500_B4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/adc.2003.044156","article-title":"Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.","volume":"89","author":"Avci","year":"2004","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021120903171812500_B5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbrc.2011.02.053","article-title":"Ceftriaxone crystallization and its potential role in kidney stone formation.","volume":"406","author":"Chutipongtanate","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2021120903171812500_B6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00467-006-0401-2","article-title":"Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.","volume":"22","author":"Mohkam","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2021120903171812500_B7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.ju.0000148801.12464.b3","article-title":"Pediatric ceftriaxone nephrolithiasis.","volume":"173","author":"Gargollo","year":"2005","journal-title":"J Urol"},{"issue":"3","key":"2021120903171812500_B8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1442-200x.2004.01900.x","article-title":"Ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge.","volume":"46","author":"Acun","year":"2004","journal-title":"Pediatr Int"},{"issue":"6","key":"2021120903171812500_B9","first-page":"1226","article-title":"Acute urine retention induced by ceftriaxone.","volume":"22","author":"Akl","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"2021120903171812500_B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11255-012-0330-x","article-title":"Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.","volume":"45","author":"Li","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2021120903171812500_B11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.20839","article-title":"Ceftriaxone induced hemolysis complicated by acute renal failure.","volume":"50","author":"Kapur","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2021120903171812500_B12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00467-011-2038-z","article-title":"Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis.","volume":"27","author":"Kimata","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2021120903171812500_B13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0272-6386(12)70348-7","article-title":"Reflex anuria and uremia from unilateral ureteral obstruction.","volume":"22","author":"Maletz","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2021120903171812500_B14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000049074","article-title":"Reflex anuria from unilateral ureteral obstruction.","volume":"90","author":"Catalano","year":"2002","journal-title":"Nephron"},{"issue":"5","key":"2021120903171812500_B15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00240-010-0279-0","article-title":"Melamine-induced infant urinary calculi: a report on 24 cases and a 1-year follow-up.","volume":"38","author":"Zhang","year":"2010","journal-title":"Urol Res"},{"issue":"3","key":"2021120903171812500_B16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-4295(00)01030-X","article-title":"Ureteropelvic junction obstruction and coexisting renal calculi in children: role of metabolic abnormalities.","volume":"57","author":"Tekin","year":"2001","journal-title":"Urology"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/133\/4\/e917\/1099407\/peds_2013-2103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/133\/4\/e917\/1099407\/peds_2013-2103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T17:35:51Z","timestamp":1639071351000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/133\/4\/e917\/32684\/Ceftriaxone-and-Acute-Renal-Failure-in-Children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,1]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-2103","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}